Repeated measurement of the novel atrial biomarker BMP10 improves risk stratification in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Konstantinos Ioannis Gkarmiris

Uppsala University Hospital, Uppsala (Sweden)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Professor G. Lip (Liverpool, GB)

Presentation thumbnail

Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

Doctor R. Aggarwal (Boston, US)

Abstract Slides Video

Presentation thumbnail

Differences in causality between exposures and stroke subtypes: a mendelian randomisation approach

Associate Professor G. Klappacher (Vienna, AT)

Abstract Slides Video

Presentation thumbnail

Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

Doctor M. Anjum (Baerum, NO)

Abstract Slides Video

Access the full session

Session thumbnail

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

Increased circulating BMP10 levels are associated with late postoperative atrial fibrillation after cardiac surgery and left atrial endomysial fibrosis

Congress Presentation

State-of-the-art lecture on stroke prevention in atrial fibrillation

Congress Presentation

Proteomic and genomic evaluation of plasma protein biomarkers for atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources